Microfluidics Market
Microfluidics Market Forecasts to 2030 - Global Analysis By Product Type (Microfluidic-Based Devices, Microfluidic Components and Other Product Types), Material, Technology, Application, End User and By Geography
According to Stratistics MRC, the Global Microfluidics Market is accounted for $25.6 billion in 2024 and is expected to reach $59.3 billion by 2030 growing at a CAGR of 15.0% during the forecast period. Microfluidics is a multidisciplinary field that deals with the precise control and manipulation of small volumes of fluids, typically on the microliter or nanoliter scale, within microfabricated devices. These devices, often referred to as lab-on-a-chip systems, integrate various components such as channels, valves, pumps, and sensors, allowing for the precise handling, mixing, and analysis of fluids. Microfluidic devices also play a crucial role in medical diagnostics, enabling the detection of diseases, monitoring of biomarkers, and drug delivery. The miniaturization, automation, and versatility offered by microfluidics have revolutionized scientific research and have the potential to significantly impact various industries in the future.
Market Dynamics:
Driver:
Rising demand for point-of-care (POC) diagnostics
POC diagnostics require compact, efficient, and cost-effective solutions to deliver quick and accurate results at the patient's location, reducing the need for centralized laboratory testing. Microfluidic technologies, with their capability to manipulate small volumes of fluids, perfectly meet these requirements. They enhance the sensitivity and speed of diagnostic tests while enabling multiplexing and integration of complex assays in portable formats. This demand is driving innovations and investments in microfluidic devices, leading to advancements in lab-on-a-chip technologies and integrated diagnostic platforms. As a result, the microfluidics market is experiencing robust growth.
Restraint:
Complexity of microfluidic design and operation
Designing microfluidic systems requires sophisticated engineering and precise fabrication techniques, which can be costly and time-consuming. These complexities often lead to higher production costs, making microfluidic devices less economically attractive compared to traditional diagnostic methods. Additionally, the intricate nature of microfluidic operations demands specialized knowledge and skills, potentially limiting widespread adoption in clinical and research settings due to the necessity for extensive training. Moreover, integrating microfluidic systems with existing laboratory infrastructure and ensuring their reliability and reproducibility can be challenging.
Opportunity:
Technological advancements and expanding applications
Innovations in microfabrication techniques, material sciences, and integration of digital technologies have enhanced the precision, efficiency, and functionality of microfluidic devices. These advancements enable the development of sophisticated lab-on-a-chip systems capable of performing complex biochemical analyses with high accuracy and speed. The expanding applications of microfluidics in areas such as medical diagnostics, drug delivery, environmental monitoring, and food safety are broadening its market scope.
Threat:
Lengthy and complex regulatory approval process
Stringent regulatory requirements for medical devices, particularly those involving new technologies, can lead to prolonged approval timelines and increased costs for manufacturers. These delays can slow down the time-to-market for innovative microfluidic solutions, reducing their competitive advantage and hindering timely access to advanced diagnostics and treatment options. Additionally, navigating the complex regulatory landscape requires substantial resources and expertise, which can be particularly challenging for smaller companies and startups.
Covid-19 Impact
Microfluidic devices, with their ability to process small fluid volumes efficiently, became crucial for developing quick, point-of-care COVID-19 tests. The pandemic accelerated innovations and investments in microfluidic technologies to meet the high demand for scalable and cost-effective diagnostic solutions. Additionally, the heightened awareness of the importance of quick diagnostics has expanded the applications of microfluidics beyond COVID-19, promoting broader adoption in infectious di
The microfluidic-based devices segment is expected to be the largest during the forecast period
The microfluidic-based devices is expected to be the largest during the forecast period as these devices offer precise control over small fluid volumes, enabling high-throughput screening, rapid diagnostics, and efficient drug delivery systems. Their ability to integrate multiple laboratory functions on a single chip reduces costs and enhances portability and efficiency in various applications, including medical diagnostics, environmental monitoring, and pharmaceutical research. The rise of lab-on-a-chip technologies exemplifies this impact, facilitating quick, accurate testing at the point-of-care.
The silicon segment is expected to have the highest CAGR during the forecast period
The silicon segment is expected to have the highest CAGR during the forecast period due to its excellent material properties, including high precision in microfabrication, robustness, and biocompatibility. Silicon's use in manufacturing microfluidic devices enables the creation of intricate and reliable structures essential for applications in diagnostics, drug delivery, and biological research. Its thermal conductivity and electrical properties are beneficial for integrating sensors and electronic components. However, the high cost and complexity of silicon-based fabrication can limit accessibility and scalability.
Region with largest share:
North America is projected to hold the largest market share during the forecast period due to factors such as the well-established healthcare system, the higher adoption of novel therapeutics among the general population, and the increasing prevalence of infectious and chronic diseases among the region's population. Moreover the rising burden of cancer is also expected to fuel the demand for microfluidics. For instance, in January 2024, according to the American Cancer Society, it was estimated that more than 2.0 million cancer cases would be diagnosed in the United States in 2024, an increase from 1.9 million cancer cases in 2023. Hence, the country's growing burden of cancer is expected to fuel the demand for microfluidics and favor market growth.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to rising demand for portable and cost-effective diagnostic devices, advancements in microfabrication technologies, and government initiatives supporting research and development in the region. Countries like China, Japan, and South Korea are at the forefront of market growth, fueled by their strong manufacturing capabilities and investments in healthcare infrastructure. Additionally, collaborations between academic institutions and industry players are fostering innovation in microfluidics technology.
Key players in the market
Some of the key players in Microfluidics market include Illumina, Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Danaher, Life Technologies Corporation, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd, Abbott Laboratories, Fluidigm Corporation, Qiagen N.V., Thermo Fischer Scientific, Biomérieux, Cellix Ltd., Elveflow, Micronit Micro Technologies B.V., Standard BioTools, UFluidix, Emulate Inc., Dolomite Microfluidics and Sphere Fluidics Limited
Key Developments:
In June 2024, Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost. XLEAP-SBS chemistry is a faster, higher quality, and more robust sequencing-by-synthesis chemistry that delivers approximately 20% faster turnaround times.
In June 2024, Agilent Announces Cutting-Edge Advances in GC/MS and LC/Q-TOF Technology at ASMS 2024. These instruments exemplify Agilent’s unwavering commitment to advancing scientific discovery through innovative instrumentation, significantly shaping the landscape of mass spectrometry.
In January 2024, Illumina expands collaboration with Janssen to advance molecular residual disease cancer test This collaboration will be the first relating to the development of Illumina's novel molecular residual disease (MRD) assay, a whole-genome sequencing.
Product Types Covered:
• Microfluidic-Based Devices
• Microfluidic Components
• Other Product Types
Materials Covered:
• Polymers
• Glass
• Silicon
• Other Materials
Technologies Covered:
• Micro Pumps
• Microfluidic Chips
• Micro Needles
• Micro Mixers
• Micro Valves
• Other Technologies
Applications Covered:
• In Vitro Diagnostics (IVD)
• Drug Discovery & Clinical Diagnostics
• Point-of-Care Testing (POCT)
• Genomics & Proteomics
• Cell-based Assays
• Lab-on-a-chip & Organs-on-chips
• Implantable Devices
• Other Applications
End Users Covered:
• Hospitals & Diagnostic Centers
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Microfluidics Market, By Product Type
5.1 Introduction
5.2 Microfluidic-Based Devices
5.3 Microfluidic Components
5.4 Other Product Types
6 Global Microfluidics Market, By Material
6.1 Introduction
6.2 Polymers
6.2.1 Polymethyl Methacrylate (PMMA)
6.2.2 Polydimethylsiloxane (PDMS)
6.3 Glass
6.4 Silicon
6.5 Other Materials
7 Global Microfluidics Market, By Technology
7.1 Introduction
7.2 Micro Pumps
7.3 Microfluidic Chips
7.4 Micro Needles
7.5 Micro Mixers
7.6 Micro Valves
7.7 Other Technologies
8 Global Microfluidics Market, By Application
8.1 Introduction
8.2 In Vitro Diagnostics (IVD)
8.3 Drug Discovery & Clinical Diagnostics
8.4 Point-of-Care Testing (POCT)
8.5 Genomics & Proteomics
8.6 Cell-based Assays
8.7 Lab-on-a-chip & Organs-on-chips
8.8 Implantable Devices
8.9 Other Applications
9 Global Microfluidics Market, By End User
9.1 Introduction
9.2 Hospitals & Diagnostic Centers
9.3 Academic & Research Institutes
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users
10 Global Microfluidics Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Illumina, Inc.
12.2 Agilent Technologies, Inc.
12.3 Perkinelmer, Inc.
12.4 Danaher
12.5 Life Technologies Corporation
12.6 Bio-Rad Laboratories, Inc.
12.7 Hoffmann-La Roche Ltd
12.8 Abbott Laboratories
12.9 Fluidigm Corporation
12.10 Qiagen N.V.
12.11 Thermo Fischer Scientific
12.12 Biomérieux
12.13 Cellix Ltd.
12.14 Elveflow
12.15 Micronit Micro Technologies B.V.
12.16 Standard BioTools
12.17 UFluidix
12.18 Emulate Inc.
12.19 Dolomite Microfluidics
12.20 Sphere Fluidics Limited
List of Tables
1 Global Microfluidics Market Outlook, By Region (2022-2030) ($MN)
2 Global Microfluidics Market Outlook, By Product Type (2022-2030) ($MN)
3 Global Microfluidics Market Outlook, By Microfluidic-Based Devices (2022-2030) ($MN)
4 Global Microfluidics Market Outlook, By Microfluidic Components (2022-2030) ($MN)
5 Global Microfluidics Market Outlook, By Other Product Types (2022-2030) ($MN)
6 Global Microfluidics Market Outlook, By Material (2022-2030) ($MN)
7 Global Microfluidics Market Outlook, By Polymers (2022-2030) ($MN)
8 Global Microfluidics Market Outlook, By Polymethyl Methacrylate (PMMA) (2022-2030) ($MN)
9 Global Microfluidics Market Outlook, By Polydimethylsiloxane (PDMS) (2022-2030) ($MN)
10 Global Microfluidics Market Outlook, By Glass (2022-2030) ($MN)
11 Global Microfluidics Market Outlook, By Silicon (2022-2030) ($MN)
12 Global Microfluidics Market Outlook, By Other Materials (2022-2030) ($MN)
13 Global Microfluidics Market Outlook, By Technology (2022-2030) ($MN)
14 Global Microfluidics Market Outlook, By Micro Pumps (2022-2030) ($MN)
15 Global Microfluidics Market Outlook, By Microfluidic Chips (2022-2030) ($MN)
16 Global Microfluidics Market Outlook, By Micro Needles (2022-2030) ($MN)
17 Global Microfluidics Market Outlook, By Micro Mixers (2022-2030) ($MN)
18 Global Microfluidics Market Outlook, By Micro Valves (2022-2030) ($MN)
19 Global Microfluidics Market Outlook, By Other Technologies (2022-2030) ($MN)
20 Global Microfluidics Market Outlook, By Application (2022-2030) ($MN)
21 Global Microfluidics Market Outlook, By In Vitro Diagnostics (IVD) (2022-2030) ($MN)
22 Global Microfluidics Market Outlook, By Drug Discovery & Clinical Diagnostics (2022-2030) ($MN)
23 Global Microfluidics Market Outlook, By Point-of-Care Testing (POCT) (2022-2030) ($MN)
24 Global Microfluidics Market Outlook, By Genomics & Proteomics (2022-2030) ($MN)
25 Global Microfluidics Market Outlook, By Cell-based Assays (2022-2030) ($MN)
26 Global Microfluidics Market Outlook, By Lab-on-a-chip & Organs-on-chips (2022-2030) ($MN)
27 Global Microfluidics Market Outlook, By Implantable Devices (2022-2030) ($MN)
28 Global Microfluidics Market Outlook, By Other Applications (2022-2030) ($MN)
29 Global Microfluidics Market Outlook, By End User (2022-2030) ($MN)
30 Global Microfluidics Market Outlook, By Hospitals & Diagnostic Centers (2022-2030) ($MN)
31 Global Microfluidics Market Outlook, By Academic & Research Institutes (2022-2030) ($MN)
32 Global Microfluidics Market Outlook, By Pharmaceutical & Biotechnology Companies (2022-2030) ($MN)
33 Global Microfluidics Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
